Skip to main content
. 2020 Dec 11;55(Suppl 1):181–714. doi: 10.1038/s41409-020-01120-w
Number of patients n= 21
Participating center 1
Median age and range 34 years(10 to 64 years)
Male :Female 15:6
Malignancies (AML, ALL, MDS, NHL, Hodgkin Lymphoma, CML) 17
Other hematological disorders (Aplastic anemia/marrow failure) 4
Patients in Complete remission at transplant 14
Patients with Active disease at transplant 7